Join Now

Parallel symposium 19 - WGT Atherosclerosis, Thrombosis, Lipidology and Regenerative Therapy (ATLR) - Atherosclerosis and Beyond: LDL Lowering Strategies for Management of ASCVD

Sunday, October 17th 2021 (14:05 – 15:20)


Lowering LDL level has never been easy despite the advent of more and more potent agent of antidyslipidemia. Experts in this session will show you the most updated strategy of lowering LDL in patients with ASCVD to achieve better long term prognosis


Time Topics
14:05 - 14:20 Asymptomatic Atherosclerosis: How and When to Treat it? (Teuku Heriansyah, MD)
14:20 - 14:35 Association of PCSK9 gene polymorphism and MACE in Acute Coronary Syndromes (Anwar Santoso, MD)
14:35 - 14:50 SiRNA-based Therapy as A Novel Approach in Management of LDL-C (Kausik K Ray, MD)
14:50 - 15:20 Discussion

will be updated soon
Chairperson : Sutomo Kasiman, MD
Panelist : Sony Hilal Wicaksono, MD
  Emanoel Oepangat, MD
Speaker : Teuku Heriansyah, MD
  Anwar Santoso, MD
  Kausik K. Ray, MD